TABLE 1

Clinical Characteristics of Patients in Control and AD Groups

ParameterControlAD
n912
Sex (male/female)6/36/6
Age (y)69 ± 8 (62–85)74 ± 8 (61–85)
MMSE*29.4 ± 0.7 (28–30)17.8 ± 6.8 (4–25)
Injected dose (MBq)383.3 ± 24.2 (351.5–418.1)382.6 ± 29.9 (318.2–421.8)
  • * Scores range from 0 to 30, with higher scores indicating better cognitive functioning.

  • Values are mean ± SD, with range in parentheses.